Venture Capital Report

Size: px
Start display at page:

Download "Venture Capital Report"

Transcription

1 Venture Capital Report U.S. 1Q 2018

2 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive view of the trends currently affecting the venture capital market. Highlights for 1Q 2018 include: U.S. venture capital fundraising increased in amount invested and in number of funds Venture capital investment into U.S. companies reached the highest level of the last three years Amount raised through initial public offerings (IPOs) decreased in the first quarter of 2018, mergers and acquisitions (M&As) also fell compared to the previous quarter 2

3 GROWTH EQUITY Starting this quarter, we are reporting on Growth Equity. VentureSource has always tracked this space, but until now they were excluded from the quarterly statistics. Please note that Growth deals will be included in the Later Stage category, a subsection of Venture Capital Investment. We define Growth Equity as a minority stake investment in privately owned, mature companies that meet the following criteria: No prior equity investment within the first 3 years of business operations; and A proven business model -- generating revenue or profitable; and No VC-type round series is used by the company to label the transaction; and At least one institutional investor participated in the deal. We recently reviewed our entire database to ensure that all companies and transactions are classified consistent with the above criteria. As a result of this review, we re-characterized thousands of historical deals from VC to Growth, or from Growth to VC. As with our Venture Capital statistics, we exclude companies formed for the sole purpose of acquiring other companies, properties, natural resources, or interests. We also exclude companies formed or owned by private equity firms. 3

4 VENTURE FUNDRAISING INCREASES IN U.S. DURING 1Q 2018 FUNDRAISING 140 venture capital funds collected $8.78 billion in 1Q 2018, a 68% increase in the amount raised, along with a 2% growth in the number of funds from the prior quarter. Norwest Venture Partners XIV LP was the largest U.S. venture capital fund of 1Q 2018, raising $1.5 billion and accounting for 17% of the total venture capital financing raised during the quarter U.S. VC Fundraising ( ) Based on multiple closings $16.00 $14.00 $12.00 $10.00 $8.00 $ $ $ Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Amount Raised ($B) $9.03 $13.75 $5.76 $9.14 $14.35 $11.91 $8.78 $9.43 $8.19 $14.37 $9.85 $5.21 $8.78 Number of Funds $- 4

5 LARGEST VC FUNDS RAISED IN 1Q 2018 FUNDRAISING Firm Name Fund Name Amount ($M) City State Offering Status Fund Type Fund Category Closing Type Norwest Venture Partners Norwest Venture Partners XIV LP $1, Palo Alto CA Closed Multi-stage venture capital Venture Capital Final General Catalyst Partners General Catalyst Group IX LP $1, Cambridge MA Closed Multi-stage venture capital Venture Capital Final Battery Ventures Battery Ventures XII LP $ Boston MA Closed Multi-stage venture capital Venture Capital Final Ampersand Capital Partners Ampersand 2018 LP $ Wellesley MA Closed Multi-stage venture capital Venture Capital Final Samsara BioCapital Samsara BioCapital LP $ Palo Alto CA Open Multi-stage venture capital Venture Capital First 5

6 U.S. EQUITY INVESTMENT IN 1Q 2018 INCREASES FINANCING U.S.-based companies raised $25.72 billion in 1303 equity deals in 1Q 2018, which translates to an increase of 17% in capital raised from the fourth quarter of 2017, with a 9% increase in number of deals during the same period. Healthcare received the highest amount of investment, accounting for 26.62% and growing 21% from the last quarter. Compared to the same period last year, there was a slight increase of 4%. Equity financing this quarter was the highest in the last three years. When measured against the same period last year, total capital invested rose by 30%. $30.00 $25.00 $20.00 $15.00 $10.00 $5.00 $0.00 Equity Financings into U.S.- Based, VC-backed Companies ( ) 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Amount Raised ($B) $19.80 $23.15 $23.50 $23.53 $16.24 $20.36 $18.80 $13.62 $19.76 $20.93 $23.32 $21.66 $25.72 Number of Deals

7 EQUITY FINANCINGS INTO U.S. BASED, VC BACKED COMPANIES, BY ROUND CLASS (QUARTER OVER QUARTER, ) FINANCING Number of Deals Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Restart Later Second First Seed

8 EQUITY FINANCINGS INTO U.S.-BASED, VC-BACKED COMPANIES, BY ROUND CLASS (QUARTER OVER QUARTER, ) FINANCING Amount Raised ($B) $18.00 $16.00 $14.00 $12.00 $10.00 $8.00 $6.00 $4.00 $2.00 $0.00 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Restart $0.03 $0.09 $0.06 $0.02 $0.06 $0.04 $0.54 $0.01 $0.08 $0.01 $0.05 $0.00 $0.03 Later $13.20 $15.52 $15.35 $16.60 $10.31 $10.63 $12.01 $7.66 $10.71 $12.86 $14.69 $13.52 $14.30 Second $3.12 $3.66 $3.70 $3.01 $2.25 $2.72 $2.37 $2.19 $3.90 $3.07 $3.50 $3.07 $4.23 First $2.12 $2.42 $2.57 $2.78 $2.09 $2.26 $2.93 $1.95 $3.64 $2.90 $2.13 $2.77 $4.25 Seed $0.08 $0.11 $0.09 $0.12 $0.13 $0.10 $0.10 $0.13 $0.16 $0.34 $0.32 $0.33 $0.32 8

9 EQUITY FINANCINGS INTO U.S.-BASED, VC-BACKED COMPANIES, MEDIAN DEAL SIZE ($M) ( ) FINANCING Median Equity Deal Size ($M) $7.00 $6.00 $5.00 $4.00 $3.00 $2.00 $1.00 $0.00 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Median Equity Deal Size ($M) $5.00 $5.00 $5.09 $5.00 $4.60 $4.83 $5.00 $5.00 $5.00 $5.60 $5.31 $6.00 $6.30 9

10 EQUITY FINANCINGS INTO U.S.-BASED, VC-BACKED COMPANIES, BY INDUSTRY GROUP (1Q 2018) FINANCING Healthcare received the largest investment allocation during 1Q 18 (27% of total), accumulating $6.85 billion through 250 deals. While the number of deals decreased in this quarter compared with 4Q 17, the amount invested in healthcare rose 21%. 1Q'18 Industry Breakdown By Number of Deals Business and Financial Services Consumer Goods Consumer Services Energy & Utilities Healthcare Business and Financial Services took second place with $5.89 billion across 321 deals. Compared to the performance of this sector in the last quarter, the Industrial Goods & Materials Information Technology numbers signify a 15% increase in deal flow along with a substantial rise of 39% in the amount raised. The sector s investment figure represents approximately 23% share of total equity investment into U.S. VC-backed companies for the quarter. Information Technology placed third this quarter in terms of equity financing, accounting for 21% of all 1Q 18 investment. The 377 deals drew $5.32 billion, a mere 4% increase in capital raised compared to the previous quarter. 1Q 18 Industry Breakdown By Amount Raised ($B) 5% 21% 27% 0% 23% 6% 18% Business and Financial Services Consumer Goods Consumer Services Energy & Utilities Healthcare Industrial Goods & Materials Information Technology 10

11 TOP 5 DEALS INTO VC-BACKED COMPANIES (1Q 2018) FINANCING Co. Name Location Industry Code Industry Segment Industry Group Brief Description Close Date Round Type Raised ($M) Uber Technologies Inc. San Francisco, CA Transportation Services Travel and Leisure Consumer Services Provider of an ondemand ridesharing service. 1/18/2018 VC Later 1, Round Investors (* denotes lead) TPG Capital LP, Tencent Holdings Ltd., Softbank Group Corp.*, Sequoia Capital, Dragoneer Investment Group Katerra Inc. Menlo Park, CA Building Construction Construction and Civil Engineering Business and Financial Services Provider of services and solutions for the construction industry. 1/24/2018 VC 2nd SoftBank Vision Fund* DoorDash Inc. San Francisco, CA Restaurants/ Food Service Travel and Leisure Consumer Services Provider of an ondemand delivery service that connects customers with local businesses. 3/1/2018 VC 5th Wellcome Trust Ltd., Softbank Finance Group*, Sequoia Capital, GIC Private Ltd. Moderna Therapeutics Inc. Cambridge, MA Biotechnology Therapeutics Biopharmaceuticals Healthcare Developer of messenger RNA (mrna) therapeutics and vaccines. 2/1/2018 VC 6th Viking Global Investors LP, Sequoia Capital, Pictet Asset Management SA, Julius Baer, Fidelity Management & Research Co., EDBI Pte. Ltd., BB Biotech Ventures, ArrowMark Partners, Alexandria Venture Investments Magic Leap Inc.* Dania Beach, FL Displays Electronics and Computer Hardware Information Technology Developer of an augmented reality visual computing system. 3/7/2018 Other Equity Saudi Arabia Public Investment Fund* *According to WSJ Pro VC, the company had a second closing of a Series D round after reporting in October a $502 million round lead by Temasek. Venture Source Data reported on this financing in the previous quarter. 11

12 MOST ACTIVE INVESTORS FOR U.S.-BASED, VC-BACKED COMPANIES (1Q 2018) FINANCING New Enterprise Associates Inc. Y Combinator Khosla Ventures Andreessen Horowitz GV Greycroft Partners 12

13 NUMBER OF DEALS/AMOUNT RAISED BY PRIMARY REGION (1Q 2018) FINANCING Number of Deals by Primary Region Amount Raised ($B) by Primary Region Number of Deals in 1Q 2018 by Primary Region Mid-Atlantic Midwest Central Midwest East Mountain New England Northern California 1Q Q 2018 Pacific Northwest South Central Mid-Atlantic Midwest Central Midwest East Mountain New England Northern California Pacific Northwest South Central South East Southern California $4.28 $0.39 $0.91 $0.95 $2.55 $10.58 $0.72 $0.99 $1.39 $2.95 Amount Raised ($B) in 1Q 2018 by Primary Region South East Southern California Mid-Atlantic Midwest Central Midwest East Mountain New England Northern California Pacific Northwest South Central South East Southern California 13

14 NUMBER OF DEALS/AMOUNT RAISED BY SUBREGION (1Q 2018) FINANCING Number of Deals by Subregion Number of Deals by subregion 1Q 2018 Amount Raised ($B) by subregion 1Q 2018 Austin Metro 27 $0.47 Boston Metro 91 $2.51 Chicago Metro 39 $0.59 Dallas-Fort Worth 13 $0.25 Los Angeles Metro 84 $1.99 New York Metro 186 $3.16 Orange County 24 $0.30 Potomac 34 $0.57 San Diego Metro 21 $0.51 San Francisco Bay Area 405 $10.56 Seattle Metro 39 $0.59 Subregion Breakout Number of Deals Seattle Metro San Francisco Bay Area San Diego Metro Potomac Orange County New York Metro Los Angeles Metro Dallas-Fort Worth Chicago Metro Boston Metro Austin Metro Seattle Metro San Francisco Bay Area Subregion San Diego Metro Breakout Potomac Amount Orange County Raised ($B) New York Metro Los Angeles Metro Dallas-Fort Worth Chicago Metro Boston Metro Austin Metro $0.59 $0.51 $0.57 $0.30 $0.25 $0.59 $ $3.16 $1.99 $ Amount Raised ($B) by subregion $

15 VENTURE M&A AND IPO MARKET ACTIVITY IN THE U.S. DURING 1Q 2018 LIQUIDITY Exit Opportunities for U.S. VC backed Companies ( ) Mergers and acquisitions (M&As) for venture-backed companies decreased 6% in value from 4Q 2017, with 120 deals garnering $17.31 billion. During the same period, the number of IPOs declined by 39%, as did the total amount raised. The latter experienced a 19% decrease, falling to $1.63 billion. 1Q'18 4Q'17 3Q'17 2Q'17 1Q'17 4Q'16 3Q'16 2Q'16 1Q'16 4Q'15 3Q'15 2Q'15 1Q' Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 IPOs M&As

16 U.S. VC-BACKED M&As ( ) LIQUIDITY U.S. VC-backed M&A Activity ( ) 120 M&As of venture-backed companies in the U.S. amounted to $17.31 billion during 1Q Compared to 4Q 2017, when a total of 156 transactions accumulated $18.40 billion, both number of deals and amount raised decreased by 23% and 6%, respectively. The largest M&A of the quarter was IO Data Centers LLC, which was acquired by Iron Mountain Inc. (NYSE: IRM) for $1.34 billion. $30.00 $25.00 $20.00 $15.00 $10.00 $5.00 $- 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Amount Paid ($B) $15.66 $11.88 $19.71 $19.56 $24.01 $26.17 $25.89 $22.17 $23.24 $20.08 $22.10 $18.40 $17.31 Number of M&As

17 TOP 3 U.S. M&As (1Q 2018) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Round Type Amount Paid ($M) Acquirer IO Data Centers LLC Phoenix, AZ Provider of wholesale data center and colocation services. Data Management Services Business Support Services Business and Financial Services 1/10/2018 Acquisition $1, Iron Mountain Inc. (NYSE: IRM) Impact San Diego, CA Biomedicines Inc.* Developer of treatments for patients with myeloproliferative neoplasms and other types of cancer. Biotechnology Therapeutics Biopharmaceuticals Healthcare 3/31/2018 Acquisition $1, Celgene Corp. (NASDAQ: CELG) Bot Home Automation Inc. Santa Monica, CA Provider of a wireless video camera doorbell security device. Security Products Aerospace and Defense Industrial Goods and Materials 2/27/2018 Acquisition $1, Amazon.com Inc. (NASDAQ: AMZN) *The company was acquired for $1.1 billion upfront and up to $ 1.25 billion in contingent payments based on regulatory approval milestones for myelofibrosis. 17

18 U.S. VC-BACKED IPOs ( ) LIQUIDITY U.S. VC-backed IPO Activity ( ) 14 venture-backed companies raised $1.63 billion through public offerings in 1Q Both number of deals and capital raised experienced a significant drop from the last quarter, 39% and 19%, respectively. Despite the decline, Dropbox Inc. s IPO raised almost twice as much as last quarters biggest IPO. The company, now quoted in the Nasdaq Stock Exchange under the DBX ticker symbol, collected $ million and was valued at $8.33 billion. $4.50 $4.00 $3.50 $3.00 $2.50 $2.00 $1.50 $1.00 $ $- 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Raised ($B) through IPO $0.93 $2.57 $1.60 $1.36 $0.38 $0.79 $0.99 $0.69 $3.95 $1.75 $0.62 $2.02 $1.63 Number of IPOs

19 TOP 3 U.S. IPOs (1Q 2018) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Round Type Raised through IPO ($M) Exchange Dropbox Inc. San Francisco, CA Provider of cloud storage services. Business Applications Software Software Information Technology 3/23/2018 IPO $563 Nasdaq: DBX Zscaler Inc. San Jose, CA Provider of multi-tenant software-as-a-service (SaaS) security services. Network / Systems Management Software Software Information Technology 3/16/2018 IPO $192 NASDAQ: ZS Homology Medicines Inc. Bedford, MA Developer of gene editing and gene therapy technologies. Biotechnology Therapeutics Biopharmaceuticals Healthcare 3/27/2018 IPO $144 NASDAQ: FIXX 19

20 ABOUT US Dow Jones VentureSource helps venture capitalists, corporate development executives, investment bankers and service providers find deal and partnership opportunities, perform comprehensive due diligence and examine trends in venture capital investment, fund-raising and liquidity. It provides accurate, comprehensive data on venture-backed companies including their investors and executives in every region, industry and stage of development throughout the world. The investment figures included in this release are based on aggregate findings of Dow Jones' proprietary research and are contained in VentureSource. This data was collected through surveys of professional firms, interviews with company executives, and from secondary sources. These venture capital statistics cover equity investments into early stage, innovative companies and do not include companies receiving funding solely from corporate, individual, and/or government investors. Figures contained throughout the report current at time of editorial but are subject to change without notice. No statement herein is to be construed as a recommendation to buy or sell securities or to provide investment advice. 20

21 ABOUT DOW JONES Dow Jones is a global provider of news and business information, delivering content to consumers and organizations around the world across multiple formats, including print, digital, mobile and live events. Dow Jones has produced unrivaled quality content for more than 125 years and today has one of the world s largest newsgathering operations globally. It produces leading publications and products including the flagship Wall Street Journal, America s largest newspaper by paid circulation; Factiva, Barron s, MarketWatch, Financial News, DJX, Dow Jones Risk & Compliance, Dow Jones Newswires, and Dow Jones VentureSource. MEDIA CONTACT: Colleen Schwartz Colleen.Schwartz@dowjones.com 21

VentureSource U.S. -- 4Q 2013

VentureSource U.S. -- 4Q 2013 U.S. -- 4Q 2013 The following report presents DJX VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive

More information

Venture Capital Report

Venture Capital Report Venture Capital Report U.S. 4Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts

More information

Venture Capital Report

Venture Capital Report Venture Capital Report U.S. 3Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 1 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 1Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 2 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report China 4Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer

More information

VentureSource U.S. -- 3Q 2014

VentureSource U.S. -- 3Q 2014 U.S. -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

VentureSource China -- 3Q 2014

VentureSource China -- 3Q 2014 China -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, and liquidity. The included charts and graphs offer a comprehensive

More information

Venture Capital Report

Venture Capital Report Europe 4Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs

More information

VentureSource China -- 1Q 2014

VentureSource China -- 1Q 2014 China -- 1Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, and liquidity. The included charts and graphs offer a comprehensive

More information

VentureSource Europe -- 3Q 2014

VentureSource Europe -- 3Q 2014 Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 4Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION FOR IMMEDIATE RELEASE For more information: Adam Wade Dow Jones Financial Information Services (415) 439-6666 adam.wade@dowjones.com AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 4Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Research Report Q4 2017

Venture Capital Research Report Q4 2017 Venture Capital Research Report Q4 2017 As of February 9, 2018 Executive Summary VC market in the US Regional share of investment VC market in the SF Bay Area Annual VC investment in the SF Bay Area VC

More information

Silicon Valley Venture Capital Survey Second Quarter 2018

Silicon Valley Venture Capital Survey Second Quarter 2018 fenwick & west Silicon Valley Venture Capital Survey Second Quarter 2018 Full Analysis Silicon Valley Venture Capital Survey Second Quarter 2018 fenwick & west Full Analysis Cynthia Clarfield Hess, Mark

More information

Shaking the MoneyTree TM Q Update

Shaking the MoneyTree TM Q Update www.pwc.com Shaking the MoneyTree TM Update PricewaterhouseCoopers/National Venture Capital Association MoneyTree TM Report based on data from Thomson Reuters HJ Paik Director, Emerging Company Services

More information

Shaking the MoneyTree TM Q Update

Shaking the MoneyTree TM Q Update www.pwc.com Shaking the MoneyTree TM Q1 2015 Update PricewaterhouseCoopers/National Venture Capital Association MoneyTree TM Report based on data from Thomson Reuters HJ Paik Director, Emerging Company

More information

Silicon Valley Venture Capital Survey Third Quarter 2017

Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west Silicon Valley Venture Capital Survey Third Quarter 2017 Full Analysis Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west Full Analysis Cynthia Clarfield Hess, Mark

More information

MoneyTree Report Q PricewaterhouseCoopers National Venture Capital Association. Data provide by Thomson Reuters.

MoneyTree Report Q PricewaterhouseCoopers National Venture Capital Association. Data provide by Thomson Reuters. www.pwcmoneytree.com PricewaterhouseCoopers National Venture Capital Association TM MoneyTree Report Data provide by Thomson Reuters The MoneyTree results are in! This special report provides summary results

More information

Venture Capital Industry Overview. Powered By:

Venture Capital Industry Overview. Powered By: Venture Capital Industry Overview Powered By: U.S. U.S. Fundraising Fundraising Slows in 1Q 05 Commitments to Venture Capital Funds $80 $83.5 Funds Raised ($B) $60 $40 $20 $0 $58.8 $50.5 $26.9 $17.1 $17.7

More information

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010) Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010) Background We analyzed the terms of venture financings for 126 companies headquartered in Silicon Valley that reported raising

More information

NEW GENERATION OF VCs LEADS STARTUP CEOs BACK TO THE FOLD

NEW GENERATION OF VCs LEADS STARTUP CEOs BACK TO THE FOLD April 2012 THE PENDULUM SWINGS IN FUNDING: NEW GENERATION OF VCs LEADS STARTUP CEOs BACK TO THE FOLD 2 Survey Overview The Palo Alto office of Dorsey & Whitney embarked on their second market survey of

More information

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year www.pwc.com Medtech Slowdown Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year February 2014 2 PwC US venture capital funding for

More information

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp 2Q13 Trends in Terms of Venture Financings in Silicon Valley Second Quarter 2013 Fenwi wick fenwick & west llp Silicon Valley Venture Capital Survey Second Quarter 2013 Barry Kramer and Michael Patrick

More information

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE CONTACTS Laura Cruz Tenor Communications for NVCA 1.917.406.7517 laura@tenorcom.com Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY KEEPS

More information

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease

More information

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

CANADIAN PRIVATE EQUITY BUYOUT REVIEW CANADIAN PRIVATE EQUITY BUYOUT REVIEW First Half 2016 REUTERS Table of Contents Canada s PE Buyout Market in Q2 2016 3 $ Invested and # Companies Financed 5 Top Buyout Deals 9 Canada by Market Segment

More information

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis

More information

PricewaterhouseCoopers National Venture Capital Association. Report. Data provided by Thomson Reuters

PricewaterhouseCoopers National Venture Capital Association. Report. Data provided by Thomson Reuters PricewaterhouseCoopers National Venture Capital Association Data provided by Thomson Reuters Report Q1 2010 US results The Q1 2010 MoneyTree results are in! This special report provides summary results

More information

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011)

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011) Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011) Background We analyzed the terms of venture financings for 117 companies headquartered in Silicon Valley that reported raising

More information

The percentage of Series A rounds declined significantly, to 12% of all deals.

The percentage of Series A rounds declined significantly, to 12% of all deals. Silicon Valley Venture Capital Survey Fourth Quarter 2012 Barry Kramer and Michael Patrick Fenwick fenwick & west llp Background We analyzed the terms of venture financings for 116 companies headquartered

More information

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS INDUSTRY RE FUNDS 1969 to present Industry surveys, quarterly and annual fund reports 9,240+ venture capital and private equity funds Venture capital and buyout funds that have invested in companies Name

More information

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp 3Q13 Trends in Terms of Venture Financings in Silicon Valley Third Quarter 2013 Fenwick fenwick & west llp Silicon Valley Venture Capital Survey Third Quarter 2013 Barry Kramer and Michael Patrick Fenwick

More information

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number

More information

Overview of Venture Equity

Overview of Venture Equity Overview of Venture Equity SVB Analytics Report 2017 Written by SVB Analytics: Steve Liu Managing Director sliu@svb.com Sean Lawson Senior Manager slawson2@svb.com Steven Pipp Senior Associate spipp@svb.com

More information

Digital Health Funding and M&A

Digital Health Funding and M&A Digital Health Funding and M&A 2018 Third Quarter and Nine Month Report Funding and Merger & Acquisition activity for the Digital Health sector http://www.mercomcapital.com 1 Copyright 2010-2016 Mercom

More information

2013 venture capital trends summary

2013 venture capital trends summary 213 venture capital trends summary Prepared by: Hitesh Kothari, Director, McGladrey LLP hitesh.kothari@mcgladrey.com August 213 Fundraising by venture capital funds In the first half of 213, 88 venture

More information

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp 1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Fenwick fenwick & west llp 1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Survey Introduction

More information

Average M&A Deal Size at Highest Level Since 2004

Average M&A Deal Size at Highest Level Since 2004 CONTACTS Ben Veghte NVCA 1.703.778.9292 bveghte@nvca.org Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MAINTAINS MOMENTUM WITH BEST QUARTER

More information

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000 CONTACTS Laura Cruz Tenor Communications for NVCA 1.917.406.7517 laura@tenorcom.com Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN

More information

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010 CONTACTS Channa Brooks Tenor Communications for NVCA 1.302.368.2345 channa@tenorcom.com Daniel Billings Thomson Reuters 1.646 223 5985 daniel.billings@thomsonreuters.com Exit Activity Shows Improved Signs

More information

Angel Group Update: Q2 2013

Angel Group Update: Q2 2013 Angel Group Update: Q2 2013 Table of Contents Q2 2013 Highlights p. 4 National Trends p. 6 Most Active Angels p.13 Regional Trends p. 16 Sector Trends p. 21 About the Halo Report p. 24 2 Q2 2013 Highlights

More information

2011 Angel Group Year in Review

2011 Angel Group Year in Review 2011 Angel Group Year in Review What is the Halo Report? Angel Group Investment Trends: The Angel Resource Institute, Silicon Valley Bank and CB Insights set out to raise awareness of early stage investment

More information

Software was the Most Active and Highest Value Segment in 2015 with 1,288 Transactions Totaling $61.5 Billion in Reported Deal Value.

Software was the Most Active and Highest Value Segment in 2015 with 1,288 Transactions Totaling $61.5 Billion in Reported Deal Value. 2015 Summary of M&A and Investment Activity in the : 1,903 Totaling a $99.6 Billion Software was the Most Active and Highest Value Segment in 2015 with 1,288 Totaling $61.5 Billion in Deal Value December

More information

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT A Summary of the San Diego Regional Economy Brought to you by San Diego Regional EDC analyzes key economic metrics that are important to understanding the regional economy and San Diego s standing relative

More information

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp 2012 Trends in Terms of U.S. Life Science Venture Financings Full Year 2012 Fenwick fenwick & west llp 2012 Trends in Terms of U.S. Life Science Venture Financings Full Year 2012 Survey Intro and Background

More information

Investor Presentation. November 2018

Investor Presentation. November 2018 Investor Presentation November 2018 KKR Today Private Markets Public Markets Capital Markets Principal Activities $104bn AUM $91bn AUM Global Franchise $19bn of Assets $81bn Private Equity, Growth Equity

More information

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management M&A Update 1H 2017 Accounts Receivable Management Healthcare IT Revenue Cycle Management Proven. Focused. Trusted. 301-576-4000 www.greenberg-advisors.com Proven. Focused. Trusted Revenue Cycle Management

More information

2 nd Quarter Earnings Conference Call

2 nd Quarter Earnings Conference Call 2 nd Quarter Earnings Conference Call KKR & Co. Inc. Investor Update July 26, 2018 Recent Milestones K-1 $ Converted to a Corporation on July 1, 2018 Investor Day held on July 9, 2018 2 Key Metrics Assets

More information

4 th Quarter Earnings Conference Call

4 th Quarter Earnings Conference Call 4 th Quarter Earnings Conference Call KKR & Co. L.P. Investor Update February 8, 2018 4Q17 Reflections Fundamentals Are Strong (Dollars in millions, except per unit amounts and unless otherwise stated)

More information

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter.

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter. Moving Ahead Third-quarter Technology venture capital investment increased 33 percent yearover-year but decreased 6 percent quarter-over-quarter October 2 PwC US venture capital funding for the Technology

More information

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd. IVC-MEITAR HIGH-TECH EXITS H1/ 215 REPORT IVC-Meitar 214 Exits Report Prepared by IVC Research Center Ltd. Israeli High-Tech Exit Highlights Exit proceeds in H1/215 reached ¾ of total exits for 214 Average

More information

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018 KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018 ($ in trillions) KKR Growth in Alternative Asset Market Share KKR AUM +20% CAGR +21% CAGR Alternative AUM +12% CAGR $190 (1) ($ in billions)

More information

KKR & Co. L.P. Goldman Sachs U.S. Financial Services Conference: December 6, 2017

KKR & Co. L.P. Goldman Sachs U.S. Financial Services Conference: December 6, 2017 KKR & Co. L.P. Goldman Sachs U.S. Financial Services Conference: December 6, 2017 KKR Growth in Alternative Asset Market Share KKR AUM +20% CAGR Alternative AUM +12% CAGR ($ in trillions) ($ in billions)

More information

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

CANADIAN PRIVATE EQUITY BUYOUT REVIEW CANADIAN PRIVATE EQUITY BUYOUT REVIEW First Three Quarters 2015 REUTERS / Todd Korol Table of Contents Canada s PE Buyout Market in First 3Q 2015 3 $ Invested and # Companies Financed 5 Top Buyout Deals

More information

Michael Evan Ellis. Matters. Proskauer.com. Partner. New York

Michael Evan Ellis. Matters. Proskauer.com. Partner. New York Contact Michael Evan Ellis Partner New York +1.212.969.3543 mellis@proskauer.com Michael E. Ellis is a partner in the Corporate Department. He is a general corporate lawyer with a focus on public and private

More information

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT A Summary of the San Diego Regional Economy UNEMPLOYMENT San Diego Regional EDC analyzes key economic metrics that are important to understanding the regional economy and San Diego's standing relative

More information

State of Venture Capital in the Southeast Q Executive Summary Pacing vs. 2016*

State of Venture Capital in the Southeast Q Executive Summary Pacing vs. 2016* Executive Summary Venture capital in the U.S. continues to flow at historically high levels, largely driven by later stage deals, with total invested capital on pace through August for an all-time record

More information

1H16 Summary of M&A and Investment Activity in the. Marketing, Media, and Technology Industries. 1,509 Transactions Totaling a Reported $74.

1H16 Summary of M&A and Investment Activity in the. Marketing, Media, and Technology Industries. 1,509 Transactions Totaling a Reported $74. 1H16 Summary of M&A and Investment Activity in the : 1,509 Totaling a $74.4 Billion Digital Media/Commerce was the Most Active Segment with 614, Followed by Marketing Technology with 474 ; Digital Media/Commerce

More information

Click to edit Master title style The State of the Venture Capital Industry Click to edit Master text styles

Click to edit Master title style The State of the Venture Capital Industry Click to edit Master text styles The State of the Venture Capital Industry Bobby Franklin President Third & level CEO of NVCA Southeast Venture Conference March 16 Overview Click Venture to edit capital Master stats text at-a-glance styles

More information

Financing Emerging Growth Companies

Financing Emerging Growth Companies Financing Emerging Growth Companies July (8,15,22) 2005 Ravi Sinha/Wilson Zehr Portland State University School of Business July 8, 2005 1:00 1:50 Class overview, review syllabus, grading, case studies

More information

4 th Quarter Earnings Conference Call

4 th Quarter Earnings Conference Call 4 th Quarter Earnings Conference Call KKR & Co. L.P. Investor Update February 11, 2016 Gross Returns $1B+ Carry Paying Funds Q4 and 2015 Performance Market Indices Private Equity Real Assets Alternative

More information

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT A Summary of the San Diego Regional Economy Brought to you by analyzes key economic metrics that are important to understanding the regional economy and San Diego s standing relative to other major metropolitan

More information

European Private Equity Buyout Review First Quarter Fabrizio Bensch REUTERS

European Private Equity Buyout Review First Quarter Fabrizio Bensch REUTERS European Private Equity Buyout Review First Quarter 2017 Fabrizio Bensch REUTERS Table of Contents Europe s PE Buyout Market in Q1 2017 3 Invested and # Companies Financed 4 Top PE Buyout Deals 6 Investment

More information

KKR and FS Investments Form Strategic BDC Partnership Creates the Leading $18BN Alternative Lending Platform. December 2017

KKR and FS Investments Form Strategic BDC Partnership Creates the Leading $18BN Alternative Lending Platform. December 2017 KKR and FS Investments Form Strategic BDC Partnership Creates the Leading $18BN Alternative Lending Platform December 2017 Strategic BDC Partnership Introduction On December 11, 2017, KKR and FS Investments

More information

TECH START-UP CONNECTING ACROSS GEOGRAPHIES

TECH START-UP CONNECTING ACROSS GEOGRAPHIES #ML15MayRathon TECH START-UP CONNECTING ACROSS GEOGRAPHIES Andrew Ray, Partner, Washington DC William Perkins, Partner, Boston James Chapman, Partner, Silicon Valley Joseph Statter, Managing Director,

More information

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT A Summary of the San Diego Regional Economy Brought to you by San Diego Regional EDC analyzes key economic metrics that are important to understanding the regional economy and San Diego s standing relative

More information

Raising Capital. Get the Money You Need to Grow Your Business. Third Edition. Andrew J. Sherman

Raising Capital. Get the Money You Need to Grow Your Business. Third Edition. Andrew J. Sherman \ Raising Capital Get the Money You Need to Grow Your Business Third Edition Andrew J. Sherman AMACOM American Management Association New York Atlanta Brussels Chicago Mexico City San Francisco Shanghai

More information

4 th Quarter Earnings Conference Call

4 th Quarter Earnings Conference Call 4 th Quarter Earnings Conference Call KKR & Co. L.P. Investor Update February 9, 2017 Healthy Level of New Capital Raised Year-Over-Year Capital Inflows Driving Asset Growth ($ in billions) $92 +11% $101

More information

Private Equity Market Update. February 2013

Private Equity Market Update. February 2013 Private Equity Market Update February 213 U.S. Private Equity Deal Activity Deal activity in the first three quarters of 212 was lower than the corresponding quarters in 211 due to a number of factors.

More information

Florida Venture Factbook

Florida Venture Factbook S E AT T L E SAN FRANCISCO NEW YORK LONDON Florida Venture Factbook 2019 pitchbook.com US + 1 206.623.1986 UK + 44 (0)207.190.9809 demo@pitchbook.com PG 1 Dear Attendee, On behalf of the Florida Venture

More information

4 th Quarter Earnings Conference Call

4 th Quarter Earnings Conference Call 4 th Quarter Earnings Conference Call KKR & Co. Inc. Investor Update February 1, 2019 Key Metrics Assets Under Management Management Fees ($ in billions) ($ in millions) $195 $1,069 $168 $905 $100 $107

More information

Trends in Healthcare Investments and Exits 2018

Trends in Healthcare Investments and Exits 2018 Trends in Healthcare Investments and Exits 208 208 Massachusetts Life Science Innovation Day Clark Hayes Managing Director Life Science/Healthcare Northeast Head of Business Development SVB Corporate Overview

More information

Venture financings in 3Q12 continued to show solid price increases from their prior round, but 3Q12 was not as strong as 2Q12.

Venture financings in 3Q12 continued to show solid price increases from their prior round, but 3Q12 was not as strong as 2Q12. Silicon Valley Venture Capital Survey Third Quarter 2012 Barry Kramer and Michael Patrick Fenwick fenwick & west llp Background We analyzed the terms of venture financings for 117 companies headquartered

More information

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT A Summary of the San Diego Regional Economy Brought to you by San Diego Regional EDC analyzes key economic metrics that are important to understanding the regional economy and San Diego s standing relative

More information

Venture capital - An introduction into the nature of venture capital

Venture capital - An introduction into the nature of venture capital 08-4-2000 Venture capital - An introduction into the nature of venture capital Boris Brosowski South Africa Table of contents: 1. INTRODUCTION... 3 2. THE NATURE OF VENTURE CAPITAL... 3 2.1. WHAT IS VENTURE

More information

Advised Mubadala Development Company PJSC in connection with the sale of interests in a ports operating company.

Advised Mubadala Development Company PJSC in connection with the sale of interests in a ports operating company. Simon Rahimzada Partner Corporate, Finance and Investments Abu Dhabi: +971 2 596 7002 srahimzada@kslaw.com Simon Rahimzada specializes in cross-border acquisitions, equity capital markets (including IPOs

More information

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Israel Venture Capital Investments Report Q3 2017

Israel Venture Capital Investments Report Q3 2017 Israel Venture Capital Investments Report Q3 2017 NOVEMBER 2017 Summary of Israeli Venture Capital Raising Q3/2017 +14% from Q2/2017 Israeli high-tech capital raising summed up to $1.44B @ ALL RIGHTS RESERVED.

More information

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value jd1 3Q17 Summary of M&A and Investment Activity in the : 814 Totaling a $49.4 Billion Software was the Most Active and Highest Value Segment in 3Q17 with 606 Totaling $29.4 Billion in Deal Value During

More information

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA Press release Baar, 28 January 2008 Attractive portfolio of investments in biotech and medical technology to be opened to the public HBM BioVentures announces further information of its planned IPO on

More information

1 st Quarter Earnings Conference Call

1 st Quarter Earnings Conference Call 1 st Quarter Earnings Conference Call KKR & Co. L.P. Investor Update April 27, 2017 1Q17 Reflections Key Business Themes Performance this quarter was strong as our model enabled us to capture more of everything

More information

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by: 4Q 2012 Private Equity Company Inventory Report Sponsored by: www.newstarfin.com Introduction In the last few quarters, an overwhelming number of the inquiries coming in to the Research Team have centered

More information

What s Hot? The M&A and Funding Landscape for Embedded Vision Companies

What s Hot? The M&A and Funding Landscape for Embedded Vision Companies What s Hot? The M&A and Funding Landscape for Embedded Vision Companies Dr. Rudolph Burger May 2018 Copyright 2018 Woodside Capital Partners 1 Questions Addressed 1. How have we segmented the embedded

More information

2018 Midwest Startup and Venture Capital Market Analysis. Hyde Park Angels Exclusive Report

2018 Midwest Startup and Venture Capital Market Analysis. Hyde Park Angels Exclusive Report 2018 Midwest Startup and Venture Capital Market Analysis Hyde Park Angels Exclusive Report Table of Contents 1 Introduction, page 3 2 The Great Lakes Leads Among Tier 2 Regions, page 5 3 Midwest Investment

More information

Silicon Valley Venture Capital Survey Third Quarter 2017

Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west Silicon Valley Venture Capital Survey Third Quarter 2017 First Look Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west First Look Cynthia Clarfield Hess, Mark Leahy

More information

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business

More information

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT Contacts: Clare Chachere, PwC US, 512-867-8737, clare.chachere@us.pwc.com Jeffrey Davidson, Brainerd Communicators for PwC, 212-739-6733, davidson@braincomm.com Ben Veghte, NVCA, 703-778-9292, bveghte@nvca.org

More information

Understanding Venture Capital

Understanding Venture Capital Understanding Venture capitalists believe innovation is the foundation of Michigan s growing economy. As a result, over the last 15 years, the venture capital industry has become a significant driver in

More information

Part of the in crowd

Part of the in crowd Part of the in crowd As venture capital enters a new cycle, co-head of global venture fund investment for Adams Street Partners Brijesh Jeevarathnam tells Marine Cole how having access to the best funds

More information

FINC915 Venture Lab Participating Firms: FALL 2009

FINC915 Venture Lab Participating Firms: FALL 2009 FINC915 Venture Lab Participating Firms: FALL 2009 and allowing the fund members to capitalize on high-growth opportunities. LOCAL FIRMS: MK Capital Task description: various Location: Northbrook, IL Fund

More information

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Steve Bengston

Steve Bengston VC Outlook 2009: Looking Down the Money Trail Steve Bengston steve.bengston@us.pwc.com 650 281 9843 PricewaterhouseCoopers/ National Venture Capital Association MoneyTree Report MoneyTree Total Investments:

More information

Carroll Co-Invest Fund I, LP Investor Update, Q4 2013

Carroll Co-Invest Fund I, LP Investor Update, Q4 2013 Carroll Co-Invest Fund I, LP Investor Update, Q4 2013 January 31, 2014 We are pleased to report that the Carroll Co-Invest Fund I concluded the 4th quarter 2013 with continued strong performance across

More information

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information